The #1st choice for food, pharma, and feed ingredients
Bioseutica is a world-leading ingredients company whose natural proteins and enzymes are innovative and selected as the first choice for food, pharma, and feed ingredients. Bioseutica aims to become a world market leader catalyzing responsible development of natural high-quality proteins and enzymes. Bioseutica is committed to scientific research leading to innovative products and proprietary technologies. Bioseutica focuses on the global supply of the highest quality bioactive proteins, including egg derived proteins, lysozyme, avidin and ovotransferrin, pancreatic enzymes and specialty products, food ingredients, and feed additives, designed for antibiotic-free livestock, such as aqua, poultry, and swine, and pets. Bioseutica’s manufacturing processes are built on high-end, cutting-edge proprietary technology and allow us to produce ingredients of highest purities in our manufacturing facilities in Canada and Europe.
Neova Technologies Inc. and Fordras are part of Bioseutica Group. Neova Technologies Inc. draws on almost thirty years of expertise in bioseparation and protein fractionation, building its international reputation on quality and service. Fordras has been serving the pharmaceutical and food industries since 1983.
Bioseutica is a member of DCAT, The Drug, Chemical & Associated Technologies Association (DCAT) powers relationships and industry knowledge for companies engaged in the business of pharmaceutical development and manufacturing. DCAT is a 501(c)6, not-for-profit, member-supported, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies. Founded in 1890, DCAT has been providing a life-long collegial community for industry representatives for over 125 years. The Drug, Chemical & Associated Technologies Association (DCAT) is a not-for-profit, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development, and manufacturing services, and related technologies. We are committed to providing programs, events, and services that help our members meet their business objectives, expand their network of customers and suppliers, and gain insight into industry trends, markets, and those issues impacting pharmaceutical development and manufacturing.
Each of Bioseutica's affiliates holds a number of certificates attesting the Company’s commitment to the highest possible quality standards.
- HACCP certification for our plants in North America
- Lysozyme Kosher certification
- Lysozyme Halal certification
- GMP certificates for Lysozyme plants in EU
- Lysozyme is affirmed as GRAS by the US Fed. Register of rules and regulations since 1998
- GDP by Swissmedic
- FSSC 22000
NA2R® is a clinically proven natural ingredient for the novel food/nootropics industry. Its daily consumption leads to increased brain serotonin levels, exerting physiologically beneficial effects on brain functions like the mood that, in turn, could promote the feeling of well-being, particularly during stressful times, as well as help emotional and cognitive functions.
Lysozyme, one of the most powerful natural antibacterial and antiviral compounds known to man, has been used in foods and pharmaceuticals for over three decades as it naturally inhibits the growth of many spoilage organisms, increases a healthy shelf life and ensures food safety. It also boosts the immunity system.
AVIDIN is a glycoprotein extracted from egg white using ion-exchange or affinity chromatography. Its biological importance was discovered in 1926 when rats were fed egg white and developed dermatitis, loss of hair and disruption of muscular co-ordination.
OVOTRANSFERRIN also called Conalbumin, is a glycoprotein with a molecular weight of 76,000. OVOTRANSFERRIN comprises approximately 13% of the protein content of egg albumen. More than sixty years ago, researchers determined
Zeewolde, March 28, 2020
The COVID-19 pandemic worries us all. The health and welfare of our employees and their families are first and foremost in our mind and we take our responsibility to provide a safe and secure workplace very seriously. As a supplier to the food and pharmaceutical sectors, the manufacturing we do is an essential service and so we continue to manufacture products during this time, however we are taking some exceptional measures to protect the health of our employees and their families, in all our sites.
Our food production plant in Zeewolde (NL) has been inspected by FDA in October 2019, in accordance with “Preventive Controls and Sanitary Human Food Operations-7303.040 Domestic and Imported Nutrition Labelling and Education Act of 1990 and MARCS # 126299”. No FDA-483, Inspectional Observations, has been issued and the production site is resulted to be in compliance with the above rules.